Suppr超能文献

人类T淋巴细胞中的HLA I类特异性抑制性受体:白细胞介素15诱导超抗原或同种异体抗原激活的CD8 + T细胞中CD94 / NKG2A的表达。

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

作者信息

Mingari M C, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L

机构信息

Dipartimento di Oncologia Clinica e Sperimentale, Università di Genova, Italy.

出版信息

Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1172-7. doi: 10.1073/pnas.95.3.1172.

Abstract

A fraction of human T lymphocytes, predominantly CD8+, express receptors for HLA class I molecules typical of natural killer cells (natural killer receptors or NKRs) that inhibit T cell receptor-mediated functions. Herein, we analyzed possible mechanism(s) leading to the expression of NKRs by T cells responding to superantigens or allogeneic cells in vitro. We show that, in the presence of interleukin 15 (IL-15), T cells (depleted of NKR+ cells) responding to toxic shock syndrome toxin 1 de novo express CD94, a molecule that is part of a heterodimeric NKR with a broad specificity for different HLA class I alleles. Maximal CD94 expression occurred when IL-15 was added shortly after the cells were placed into culture, and CD94 expression started 4-6 days after addition of IL-15. Although both CD4+ and CD8+ cells expressed CD94, the simultaneous expression of NKG2A (i.e., the other component of the CD94/NKG2A inhibitory NKR) was confined to CD8+ cells. Similar data were obtained in T cell populations activated in mixed lymphocyte cultures in the presence of IL-15. The expression of CD94/NKG2A led to an impairment of allo-specific cytolytic activity by mixed lymphocyte culture-derived T cell populations or clones. Remarkably, cytolysis could be restored by the addition of anti-CD94 mAb, i.e., by masking the inhibitory NKRs.

摘要

一小部分人类T淋巴细胞(主要是CD8+)表达自然杀伤细胞典型的HLA I类分子受体(自然杀伤受体或NKRs),这些受体可抑制T细胞受体介导的功能。在此,我们分析了体外对超抗原或同种异体细胞作出反应的T细胞表达NKRs的可能机制。我们发现,在白细胞介素15(IL-15)存在的情况下,对中毒性休克综合征毒素1作出反应的T细胞(去除了NKR+细胞)会重新表达CD94,CD94是一种异二聚体NKR的组成部分,对不同的HLA I类等位基因具有广泛的特异性。当细胞接种后不久加入IL-15时,CD94表达达到最大值,并且在加入IL-15后4 - 6天开始表达CD94。虽然CD4+和CD8+细胞都表达CD94,但NKG2A(即CD94/NKG2A抑制性NKR的另一个组成部分)的同时表达仅限于CD8+细胞。在存在IL-15的混合淋巴细胞培养中激活的T细胞群体中也获得了类似的数据。CD94/NKG2A的表达导致混合淋巴细胞培养来源的T细胞群体或克隆的同种异体特异性细胞溶解活性受损。值得注意的是,通过添加抗CD94单克隆抗体,即通过掩盖抑制性NKRs,可以恢复细胞溶解作用。

相似文献

引用本文的文献

8
Dimerization of Transmembrane Proteins in Cancer Immunotherapy.癌症免疫治疗中跨膜蛋白的二聚化
Membranes (Basel). 2023 Mar 30;13(4):393. doi: 10.3390/membranes13040393.
9
An updated review of the immunological mechanisms of keloid scars.瘢痕疙瘩免疫发病机制的最新研究进展
Front Immunol. 2023 Mar 22;14:1117630. doi: 10.3389/fimmu.2023.1117630. eCollection 2023.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验